- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.15 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x K: POTASSIUM ION(Non-covalent)
- 4 x PG5: 1-METHOXY-2-[2-(2-METHOXY-ETHOXY]-ETHANE(Non-covalent)
PG5.2: 5 residues within 4Å:- Chain A: F.130, T.180, Y.186, W.189, Y.192
No protein-ligand interaction detected (PLIP)PG5.10: 5 residues within 4Å:- Chain B: F.130, T.180, Y.186, W.189, Y.192
No protein-ligand interaction detected (PLIP)PG5.17: 6 residues within 4Å:- Chain C: F.130, T.180, Y.186, W.189, Y.192, L.230
No protein-ligand interaction detected (PLIP)PG5.24: 5 residues within 4Å:- Chain D: F.130, T.180, Y.186, W.189, Y.192
1 PLIP interactions:1 interactions with chain D- Water bridges: D:T.180
- 19 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.3: 6 residues within 4Å:- Chain A: A.197, L.200, R.204
- Chain B: A.197, L.200, R.204
Ligand excluded by PLIPEDO.4: 5 residues within 4Å:- Chain A: D.136, T.137, M.138
- Chain B: Q.159
- Ligands: EDO.11
Ligand excluded by PLIPEDO.5: 6 residues within 4Å:- Chain A: A.110, R.111, V.114, A.160, A.163, P.164
Ligand excluded by PLIPEDO.6: 7 residues within 4Å:- Chain A: V.183, T.184, V.283, P.285
- Chain D: V.183, T.184, V.283
Ligand excluded by PLIPEDO.7: 6 residues within 4Å:- Chain A: P.103, A.107, Y.156, Q.159
- Chain B: P.140
- Ligands: EDO.13
Ligand excluded by PLIPEDO.8: 6 residues within 4Å:- Chain A: N.126, A.127, G.128, T.176, Y.192, K.196
Ligand excluded by PLIPEDO.11: 7 residues within 4Å:- Chain A: P.140
- Chain B: P.103, A.107, Y.156, Q.159, A.160
- Ligands: EDO.4
Ligand excluded by PLIPEDO.12: 5 residues within 4Å:- Chain B: A.110, R.111, A.160, A.163, P.164
Ligand excluded by PLIPEDO.13: 5 residues within 4Å:- Chain A: Q.159
- Chain B: D.136, T.137, M.138
- Ligands: EDO.7
Ligand excluded by PLIPEDO.14: 7 residues within 4Å:- Chain B: N.126, A.127, G.128, F.130, T.176, Y.192, K.196
Ligand excluded by PLIPEDO.15: 4 residues within 4Å:- Chain B: S.101, S.144, E.145, D.148
Ligand excluded by PLIPEDO.18: 6 residues within 4Å:- Chain C: A.197, L.200, R.204
- Chain D: A.197, L.200, R.204
Ligand excluded by PLIPEDO.19: 5 residues within 4Å:- Chain B: T.184, V.283
- Chain C: T.184, V.283, P.285
Ligand excluded by PLIPEDO.20: 6 residues within 4Å:- Chain C: P.103, A.107, Y.156, Q.159, A.160
- Ligands: EDO.25
Ligand excluded by PLIPEDO.21: 3 residues within 4Å:- Chain C: D.136, M.138
- Ligands: EDO.26
Ligand excluded by PLIPEDO.22: 7 residues within 4Å:- Chain C: N.126, A.127, G.128, F.130, T.176, Y.192, K.196
Ligand excluded by PLIPEDO.25: 5 residues within 4Å:- Chain C: Q.159
- Chain D: D.136, T.137, M.138
- Ligands: EDO.20
Ligand excluded by PLIPEDO.26: 6 residues within 4Å:- Chain D: P.103, A.107, Y.156, Q.159, A.160
- Ligands: EDO.21
Ligand excluded by PLIPEDO.27: 7 residues within 4Å:- Chain D: N.126, A.127, G.128, F.130, T.176, Y.192, K.196
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Baugh, L. et al., Increasing the structural coverage of tuberculosis drug targets. Tuberculosis (Edinb) (2015)
- Release Date
- 2011-04-20
- Peptides
- short chain dehydrogenase or reductase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.15 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x K: POTASSIUM ION(Non-covalent)
- 4 x PG5: 1-METHOXY-2-[2-(2-METHOXY-ETHOXY]-ETHANE(Non-covalent)
- 19 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Baugh, L. et al., Increasing the structural coverage of tuberculosis drug targets. Tuberculosis (Edinb) (2015)
- Release Date
- 2011-04-20
- Peptides
- short chain dehydrogenase or reductase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D